Apria Home
ChannelsResourcesServicesInsuranceBranch LocatorAbout ApriaCareersHelp
 resources
Community
Health Advisors
Patient Education
Other Sources
Glossaries
Product Manuals
FAQS
News
Electronic CMN
  Search Apria articles:
 
     
 Channels
Cancer
Caregivers
Degenerative Conditions
Diabetes
Heart
Infectious Diseases
Pediatrics
Respiratory
Seniors
Sleep Disorders
 
 
   
  Increase Font Size Decrease Font Size Printer Friendly
 
  U. research lessens cerebral palsy risk: Magnesium sulfate given to expectant moms can help preemies from developing the disorder
  Carlos Mayorga
 
 

Aug. 28--Expectant mothers at high risk of giving birth prematurely can lessen their newborns' risk of cerebral palsy by taking magnesium sulfate, according to a study involving researchers at the University of Utah.

The study, published in today's issue of The New England Journal of Medicine, involved 2,241 pregnant women from across the country, including many from Utah. The majority of the women had preterm ruptured membranes before labor.

In the days before delivery, they were randomly given intravenous magnesium sulfate or a placebo.

Doctors sometimes use magnesium sulfate to stop premature labor, but the treatment is not all that effective, said Michael W. Varner, a professor and vice chair for research in Obstetrics and Gynecology at the University of Utah and one of the study's co-investigators.

But curiosity about its potential to curb cerebral palsy was raised by a study of California birth certificates. That research showed premature babies whose mothers were exposed to magnesium sulfate during birth had lower rates of the neurological disorder, Varner said.

In the new study, babies whose mothers had received the treatment:

--Showed lower rates of all forms of cerebral palsy, at 4.2 percent. Babies in the placebo group had a rate of 7.3 percent.

--Developed moderate to severe cerebral palsy at a rate of 1.9 percent. Children born to mothers who received the placebo had a rate of 3.5 percent.

The disorder, which affects a child's ability to control movement, is believed to stem from abnormal development during pregnancy, shortly after birth or in the first few years of childhood. Researchers are still unsure of its exact cause.

Christi Johnson, 27, of Spanish Fork agreed to participate in 2004, when she was told her son Tagger would be born prematurely. The boy, now a healthy 4-year-old, was born at 31 weeks and weighed about 3 pounds.

"I remember listening to all the risks and how scared I was," Johnson said. "That's when they came in and started talking to me about this study. If I can help just one baby by doing this study, it was more than worth it."

The rate of full-term babies who develop cerebral palsy is one in 1,000. But for premature babies, the rate is 20 to 50 in 1,000, Varner said.

"Cerebral palsy is a devastating lifelong problem," Varner said. "One in every 500 babies are born with it. In Utah terms, that's about two a week."

The study was co-funded by the National Institute of Neurological Disorders. Utah patients were recruited through a partnership between the University of Utah and Intermountain Healthcare.

cmayorga@sltrib.com

-----

To see more of The Salt Lake Tribune, or to subscribe to the newspaper, go to http://www.sltrib.com.

Copyright (c) 2008, The Salt Lake Tribune

Distributed by McClatchy-Tribune Information Services.

For reprints, email tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

 
 
 
 
 
Contact Us | Terms & Conditions | Privacy Policy | HIPAA Privacy Notice
 
2008 Apria Healthcare All Rights Reserved.
No duplication of any material herein is authorized without the express consent of Apria Healthcare, Inc.
Please review the Terms and Conditions of this Web site.